Cargando…
Trends in high intensity statin use among secondary prevention patients 76 years and older
BACKGROUND: High intensity statin therapy (HIST) is the gold standard therapy for decreasing the risk of recurrent atherosclerotic cardiovascular disease (ASCVD); however, little is known about the use of HIST in older adults with ASCVD. OBJECTIVES: The aim of this cross-sequential study was to dete...
Autores principales: | Wood, Michele, Delate, Thomas, Stadler, Sheila L., Denham, Anne M., Ruppe, Leslie K., Hornak, Roseanne, Olson, Kari L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centro de Investigaciones y Publicaciones Farmaceuticas
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594424/ https://www.ncbi.nlm.nih.gov/pubmed/31275492 http://dx.doi.org/10.18549/PharmPract.2019.2.1402 |
Ejemplares similares
-
Assessment of Patient Satisfaction With Telephone and Mail Interventions Provided by a Clinical Pharmacy Cardiac Risk Reduction Service
por: Holsclaw, Susan L., et al.
Publicado: (2005) -
Transthyretin Amyloid Cardiomyopathy Risk Evaluation in a Cohort of Patients With Heart Failure
por: Suh, Angie A, et al.
Publicado: (2023) -
Underutilization of Statin Therapy for Secondary Prevention of Cardiovascular Disease Among Older Adults
por: Musich, Shirley, et al.
Publicado: (2019) -
Temporal Trends of High‐Intensity Statin Therapy Among Veterans Treated With Percutaneous Coronary Intervention
por: Bin Abdulhak, Aref A., et al.
Publicado: (2018) -
Perceptions of the Value of Clinical Pharmacy Medication Review for Women During Early Pregnancy
por: Lee, Minna, et al.
Publicado: (2020)